 STAMFORD, Conn., April 29, 2022 GLOBE NEWSWIRE -- Cara Therapeutics, Inc. Nasdaq: CARA, an early commercial-stage biopharmaceutical company leading a new treatment paradigm to improve the lives of patients suffering from pruritus, today announced the Company will host a conference call and live audio webcast on Monday, May 9, 2022, at 4:30 p.m. ET to report first quarter 2022 financial results and provide a corporate update. 